in3

in3

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Edelweiss Connect (3 weeks ago)
Dynamic gene expression profiling of the HepaRG™ cell line #HepaRG #invitro #cellculture #BiotechNews See the n… https://t.co/dPow2PDDXK
Edelweiss Connect (3 weeks ago)
RT @barryhardy: Trusted Evidence in Public Health - combining #dataintegrity, #ArtificialIntelligence and #MachineLearning learning in pre…
Edelweiss Connect (5 weeks ago)
Watch our latest #SaferWorldbyDesign panel discussion: In Vitro Biology and Toxicology: Emerging Methods and Best P… https://t.co/cXF7alwRzC
Edelweiss Connect (2 months ago)
RT @DanyX23: Great thread about an interactive notebook I recently made about global inequality, recreating a chart in an article by @MaxCR…
Edelweiss Connect (3 months ago)
RT @LabsExplorer: Tomorrow's webinar >> In Vitro Biology and Toxicology: Emerging Methods and Best Practices - by @edelweissconn https://t…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA